Inicio>>Signaling Pathways>> DNA Damage/DNA Repair>> DNA/RNA Synthesis>>Silver sulfadiazine

Silver sulfadiazine

Catalog No.GC61276

La sulfadiazina de plata (AgSD), un antibiÓtico de sulfonamida, ejerce una doble acciÓn inhibitoria sobre el crecimiento bacteriano mediante su fracciÓn sulfa (SD-SDZ) que impide la absorciÓn de folato bacteriano y la subsiguiente sÍntesis de ADN.

Products are for research use only. Not for human use. We do not sell to patients.

Silver sulfadiazine Chemical Structure

Cas No.: 22199-08-2

Tamaño Precio Disponibilidad Cantidad
250mg
46,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Silver sulfadiazine (AgSD), a sulfonamide antibiotic, effects a dual inhibitory action on bacterial growth by its sulfa moiety (SD-SDZ) that prevents bacterial folate absorption and subsequent DNA synthesis. The silver that is released from Silver sulfadiazine binds and disrupts the DNA structure, precluding bacterial DNA replication[1].

Silver sulfadiazine (AgSD) is a topical antibiotic used to the research of bacterial infection in burns[2].

[1]. Strydom SJ, et al. Poly(amidoamine) dendrimer-mediated synthesis and stabilization of silver sulfonamide nanoparticles with increased antibacterial activity. Nanomedicine. 2013;9(1):85-93. [2]. Munhoz DR, et al. Alginate films functionalized with silver sulfadiazine-loaded [Mg-Al] layered double hydroxide as antimicrobial wound dressing. Int J Biol Macromol. 2019;141:504-510.

Reseñas

Review for Silver sulfadiazine

Average Rating: 5 ★★★★★ (Based on Reviews and 19 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Silver sulfadiazine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.